261 related articles for article (PubMed ID: 4905154)
21. [Asparaginase].
Boiron M; Jacquillat C; Weil M; Tanzer J; Bernard J
Presse Med (1893); 1968 Nov; 76(44):2099-101. PubMed ID: 4882819
[No Abstract] [Full Text] [Related]
22. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
Geib KR; Papazian R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
[No Abstract] [Full Text] [Related]
23. The place of the L-asparaginase in the treatment of acute leukemias.
Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L
Recent Results Cancer Res; 1970; 33():278-87. PubMed ID: 4403337
[No Abstract] [Full Text] [Related]
24. [L-asparaginase in the treatment of acute leukoses].
Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
[No Abstract] [Full Text] [Related]
25. l-asparaginase resistance in human leukemia--asparagine synthetase.
Haskell CM; Canellos GP
Biochem Pharmacol; 1969 Oct; 18(10):2578-80. PubMed ID: 4935103
[No Abstract] [Full Text] [Related]
26. Asparaginase in acute leukaemia.
Colebatch JH; Matthews RN; Gordon PM; Tan CL; Santamaria JN; Lay HN
Med J Aust; 1970 Feb; 1(6):282. PubMed ID: 5266297
[No Abstract] [Full Text] [Related]
27. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
28. L-asparaginase and human malignant disease.
Crowther D
Nature; 1971 Jan; 229(5281):168-71. PubMed ID: 4923259
[No Abstract] [Full Text] [Related]
29. Biocmical and pharmacologic effects of L-asparaginase in man.
Haskell CM; Canellos GP; Cooney DA; Hansen HH
J Lab Clin Med; 1970 May; 75(5):763-70. PubMed ID: 4909251
[No Abstract] [Full Text] [Related]
30. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
Adamson RH; Fabro S
Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425
[No Abstract] [Full Text] [Related]
31. [Immobilized asparaginase and its use in medicine].
Kozlov EA; Petriĭ OP
Vopr Med Khim; 1978; 24(6):723-33. PubMed ID: 32657
[No Abstract] [Full Text] [Related]
32. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
33. Clinical evaluation of L-asparaginase. Introduction.
Burchenal JH; Karnofsky DA
Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
[No Abstract] [Full Text] [Related]
34. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
[No Abstract] [Full Text] [Related]
35. [Asparaginase, leukemia and cancer].
Levy D; Boiron M
Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
[No Abstract] [Full Text] [Related]
36. [Results of a cooperative clinical study of Soviet L-asparaginase from E. coli].
Kondrat'eva NA; Lorie IuI; Kruglova GV; Vorob'ev AI; Brilliant MD
Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):3-9. PubMed ID: 6995975
[No Abstract] [Full Text] [Related]
37. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
Cheţa D; Micu D; Cheţa N
Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
[No Abstract] [Full Text] [Related]
38. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
[No Abstract] [Full Text] [Related]
39. [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C; Ngo Minh Man
Presse Med (1893); 1969 Mar; 77(11):385-8. PubMed ID: 4891646
[No Abstract] [Full Text] [Related]
40. [L-asparaginase in the treatment of solid tumors and leukemia].
Heim RR; Freiberg J; Gehrmann G
Dtsch Med Wochenschr; 1970 May; 95(18):989-93. PubMed ID: 5269095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
